The following is a summary of “Antibiotics use decreases survival in cutaneous squamous cell carcinoma patients receiving ...

Cemiplimab significantly reduced the risk of recurrence or death in patients with high-risk cutaneous squamous cell carcinoma ...

Ohio-based White Castle’s new president is the first non-family member to hold the role in the company’s 104-year history.

Regeneron recently presented five-years results from the phase 3 EMPOWER-Lung 1 trial of Libtayo as a first-line treatment ...

Regeneron shares have been in a bearish trend since August, losing over one third of their value. Read why I am initiating REGN stock with a buy rating.

Etsy is best for teens who don’t need a large amount of cards. And if you’re on the hunt for square business cards, invest in these vibrant contact cards. The shop allows you to pick between four font ...

Martin Luther King Jr. Day is observed on January 20, with mail and trash collection unavailable, banks and government offices closed, schools closed in some areas, and most private businesses ...

The positive trial results could help Regeneron cushion the blow of its disappointing fourth-quarter sales for Eylea, which exceeded the consensus by a modest 1% and are bogged down by the slow ...

Cancer treatment is undergoing a revolution, and immunotherapy is leading the charge. Unlike traditional methods like ...

Data from expansion arms in Phase 1/1b clinical trial evaluating WTX-124 as monotherapy expected in first half of 2025 to guide regulatory ...